Are Endocrine Tumors Hereditary? Testing Guide
At a Glance
While most endocrine tumors occur randomly, up to 40% of certain types are linked to inherited genetic syndromes like MEN1 and MEN2. If you test positive for a genetic mutation, doctors highly recommend testing your immediate family members to guide early detection and preventative care.
In this answer
3 sections
Yes, if you have an endocrine tumor, your family members might need to be tested. The likelihood of an endocrine tumor being hereditary depends heavily on the specific type of tumor you have. While roughly 10% of some endocrine tumors are linked to inherited genetic syndromes—such as Multiple Endocrine Neoplasia type 1 (MEN1) or type 2 (MEN2)—that number can be up to 40% for certain types, like pheochromocytomas [1][2]. If your medical team discovers that your tumor is caused by one of these genetic mutations, it is highly recommended that your immediate family members—such as your children, siblings, and parents—are offered genetic counseling and testing [3].
Understanding the Hereditary Connection
While most endocrine tumors happen randomly (what doctors call “sporadic”), some are hereditary [2]. This means that the genetic change that caused the tumor was passed down from a parent and can be passed on to children.
The most common genetic syndromes linked to endocrine tumors are:
- MEN1 (Multiple Endocrine Neoplasia type 1): This syndrome is caused by a change in the MEN1 gene [4]. It increases the risk for tumors in the parathyroid glands, pituitary gland, and pancreas [5].
- MEN2 (Multiple Endocrine Neoplasia type 2): Caused by a change in the RET gene, MEN2 increases the risk for a specific type of thyroid cancer (medullary thyroid carcinoma) and tumors in the adrenal glands [3][6].
- Other Syndromes: Conditions like Von Hippel-Lindau (VHL) disease or Tuberous Sclerosis Complex (TSC) can also cause hereditary endocrine tumors [7].
Because these syndromes follow an autosomal dominant pattern of inheritance, a person only needs to inherit the mutated gene from one parent to be at risk [4]. This means an individual with the mutation has a 50% chance of passing it on to each of their children.
The Role of Genetic Counseling and Testing
If your doctor suspects your tumor could be hereditary, they will likely recommend that you undergo genetic testing first [1]. If a genetic mutation like MEN1 or MEN2 is found, your doctors will suggest cascade testing. This simply means testing your closest relatives (children, siblings, and parents) to see if they share the exact same genetic mutation [3][8].
Genetic testing for your family is crucial for several reasons:
- Early Detection: If a family member tests positive, they can begin regular screening right away [9]. Finding tumors early often makes them much easier to manage.
- Preventative Action: In some cases, knowing a mutation is present allows for preventative steps. For example, individuals with a MEN2 mutation may undergo surgery to remove the thyroid gland before cancer ever develops [8][10]. (Note: The age at which this surgery happens varies widely based on the specific mutation, ranging from infancy to young adulthood. The exact timeline for testing children and considering surgery is something your genetic counselor will guide you through.)
- Targeted Care: A negative test brings immense relief. If a family member tests negative for the specific genetic mutation found in you, they do not need the intense lifelong screening required for MEN syndromes [11].
Preparing for the Process
Navigating genetic risk can be emotional for an entire family, and the decision to test is influenced by each family’s unique dynamics [12]. Genetic counseling is an essential first step. A genetic counselor can explain what the test results mean, how to communicate this information to your family (often providing letters or scripts to help you share the news), and what steps your relatives can take to protect their health.
Additionally, genetic counselors can help you navigate concerns about insurance. It is important to discuss genetic privacy laws (such as the Genetic Information Nondiscrimination Act, or GINA, in the United States) with your counselor to understand how testing might impact health or life insurance for your family members before anyone gets tested.
Common questions in this guide
Are all endocrine tumors hereditary?
What happens if I test positive for an MEN1 or MEN2 mutation?
At what age should my children be tested for an inherited endocrine tumor?
Will a negative genetic test help my family members?
Can genetic testing for endocrine tumors affect my family's insurance?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given the specific type and location of my endocrine tumor, what is the exact likelihood that it is hereditary?
- 2.Can you refer me and my family to a certified genetic counselor who specializes in endocrine or cancer genetics?
- 3.If I test positive for a mutation like MEN1 or MEN2, at what specific age should my children be tested?
- 4.What specific genetic testing panel do you recommend for my situation, and does it cover syndromes beyond MEN1 and MEN2, like VHL?
- 5.How will a positive genetic test change my personal treatment and long-term screening plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Overview of Genetically Determined Diseases/Multiple Endocrine Neoplasia Syndromes Predisposing to Endocrine Tumors.
Decmann A, Patócs A, Igaz P
Experientia supplementum (2012) 2019; (111()):105-127 doi:10.1007/978-3-030-25905-1_7.
PMID: 31588530 - 2
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability.
Raj N, Shah R, Stadler Z, et al.
JCO precision oncology 2018; (2018()) doi:10.1200/PO.17.00267.
PMID: 30687805 - 3
Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B.
Greenberg LA
Primary care 2024; (51(3)):483-494 doi:10.1016/j.pop.2024.03.006.
PMID: 39067973 - 4
MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
Grolmusz VK, Borka K, Kövesdi A, et al.
Virchows Archiv : an international journal of pathology 2017; (471(3)):401-411 doi:10.1007/s00428-017-2158-3.
PMID: 28597079 - 5
Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes.
Shariq OA, Lines KE, English KA, et al.
Surgery 2022; (171(1)):77-87 doi:10.1016/j.surg.2021.04.041.
PMID: 34183184 - 6
RET Gene Alterations in Clinical Practice: A Comprehensive Review and Database Update.
Ricciardi Tenore C, Tulli E, Perrucci A, et al.
Genes 2025; (16(12)) doi:10.3390/genes16121472.
PMID: 41465145 - 7
Hereditary Syndromes Associated with Pancreatic and Lung Neuroendocrine Tumors.
Papadopoulou-Marketou N, Tsoli M, Chatzellis E, et al.
Cancers 2024; (16(11)) doi:10.3390/cancers16112075.
PMID: 38893191 - 8
Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2.
Prete FP, Abdel-Aziz T, Morkane C, et al.
The British journal of surgery 2018; (105(10)):1319-1327 doi:10.1002/bjs.10856.
PMID: 29663329 - 9
Hereditary Endocrine Tumors and Associated Syndromes: A Narrative Review for Endocrinologists and Endocrine Surgeons.
Moore EC, Ioannou L, Ruseckaite R, et al.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2021; (27(11)):1165-1174 doi:10.1016/j.eprac.2021.07.002.
PMID: 34265452 - 10
Left anterior descending artery disease in a 27-year-old with multiple endocrine neoplasia, type 2A: A case report.
Al Salihi MO, Iyyani MK, Koilpillai S, et al.
SAGE open medical case reports 2023; (11()):2050313X231212095 doi:10.1177/2050313X231212095.
PMID: 38022857 - 11
Adolescent primary hyperparathyroidism.
Sharma A, Memon SS, Karlekar M, Bandgar T
Best practice & research. Clinical endocrinology & metabolism 2025; (39(2)):101975 doi:10.1016/j.beem.2025.101975.
PMID: 39824681 - 12
Lived experiences of undergoing regular tumor screening in patients with multiple endocrine neoplasia types 1 and 2 (MEN1/MEN2).
Klein Haneveld MJ, Valk GD, van Leeuwaarde RS
Journal of genetic counseling 2024; (33(2)):402-412 doi:10.1002/jgc4.1739.
PMID: 37357885
This page provides educational information about genetic testing for hereditary endocrine tumors. Always consult a certified genetic counselor or endocrinologist for advice specific to your family's health risks and testing timeline.
Get notified when new evidence is published on Tumor of endocrine glands.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.